Edwards Lifesciences (EW) Net Margin (2009 - 2025)

Edwards Lifesciences' Net Margin history runs 17 years deep, the most recent figure standing at 1.72% for Q4 2025.

• In Q4 2025, Net Margin fell 112.0% year-over-year to 1.72%; the TTM figure through Mar 2026 stood at 0.33% (down 4930.0% YoY), while the FY2025 annual figure was 0.22%, down 5077.0% from the prior year.
• Net Margin was 1.72% for Q4 2025 at Edwards Lifesciences, up from 0.13% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 199.89% in Q3 2024 to a low of 0.51% in Q1 2025.
• Historically, Net Margin has averaged 26.76% across 5 years, with a median of 14.72% in 2023.
• The sharpest annual moves came in 2024 and 2025: Net Margin surged 19596 bps in 2024, then sank 20002 bps in 2025.
• A 5-year view of Net Margin shows it stood at 25.22% in 2021, then surged by 268 bps to 92.67% in 2022, then slumped by 97 bps to 2.89% in 2023, then fell by 2 bps to 2.84% in 2024, then slumped by 39 bps to 1.72% in 2025.
• The last three Net Margin figures came in at 1.72% (Q4 2025), 0.13% (Q3 2025), and 0.29% (Q2 2025), per Business Quant data.